IOVA icon

Iovance Biotherapeutics

232 hedge funds and large institutions have $4.22B invested in Iovance Biotherapeutics in 2021 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 101 increasing their positions, 56 reducing their positions, and 62 closing their positions.

Holders
232
Holders Change
-18
Holders Change %
-7.2%
% of All Funds
4.05%
Holding in Top 10
7
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.12%
New
45
Increased
101
Reduced
56
Closed
62
Calls
$77.1M
Puts
$36.5M
Net Calls
+$40.6M
Net Calls Change
+$21.7M
Name Market Value Shares Shares
Change
Shares
Change %
CC
276
Centiva Capital
New York
-9,897 Closed
IMRF
277
Illinois Municipal Retirement Fund
Illinois
-9,135 Closed
PAMU
278
Pictet Asset Management (UK)
United Kingdom
-9,100 Closed
AI
279
Atom Investors
Texas
-8,172 Closed
VRS
280
Virginia Retirement Systems
Virginia
-7,900 Closed
Baird Financial Group
281
Baird Financial Group
Wisconsin
-7,325 Closed
URS
282
Utah Retirement Systems
Utah
-7,200 Closed
TCA
283
Transcend Capital Advisors
New Jersey
-6,830 Closed
Creative Planning
284
Creative Planning
Kansas
-6,554 Closed
NICM
285
Neo Ivy Capital Management
New York
-3,215 Closed
Pacer Advisors
286
Pacer Advisors
Pennsylvania
-2,187 Closed
TCWM
287
Total Clarity Wealth Management
Illinois
-1,897 Closed
SFS
288
Sowell Financial Services
Arkansas
-595 Closed
GWS
289
Glassman Wealth Services
Virginia
-267 Closed
AIC
290
Ameritas Investment Company
Nebraska
-60 Closed
CAM
291
ClariVest Asset Management
California
-9 Closed
IA
292
IFP Advisors
Florida
-4 Closed
Nomura Asset Management
293
Nomura Asset Management
Japan
HT
294
HAP Trading
New York
TCM
295
Tradewinds Capital Management
Washington
$0 3
TWA
296
TCI Wealth Advisors
Arizona
$0 17
SM
297
SG3 Management
Puerto Rico
CFGS
298
Concourse Financial Group Securities
Alabama
CCM
299
CloudAlpha Capital Management
Hong Kong